American Shared Hospital Services Announces Proposed 2016 CMS Gamma Knife and Proton Therapy Reimbursement Rates
July 27 2015 - 8:03AM
Business Wire
AMERICAN SHARED HOSPITAL SERVICES (NYSE MKT:AMS),
a leading provider of turnkey technology solutions for advanced
radiosurgical and radiation therapy services, announced today that
the Centers for Medicare and Medicaid Services (CMS) has posted its
proposed Medicare hospital outpatient prospective payment rates for
calendar year 2016.
CMS’s proposed 2016 proton therapy delivery code rates per daily
session are $519, a 2.1% increase ($508 in 2015) for a simple
treatment without compensation, $1,152, a 7.5% increase ($1,072 in
2015) for a simple treatment with compensation, and $1,152, a 7.5%
increase ($1,072 in 2015) for an intermediate or complex
treatment.
Also, CMS is proposing a modification of the comprehensive APC
for both Gamma Knife and LINAC one session cranial radiosurgery.
The proposed comprehensive reimbursement rate of approximately
$7,347 will be inclusive of the delivery and certain ancillary
codes but exclusive of co-insurance payments or other adjustments.
CMS further proposes that effective in 2016, treatment planning and
MRI treatment imaging codes again be billed and reimbursed
separately. The average proposed 2016 CMS reimbursement rate for
delivery and separately reimbursable ancillary codes (exclusive of
co-insurance and other adjustments) is estimated at $8,827 compared
to the current rate of $9,768, a decrease of 9.6%.
CMS will accept comments on these proposals until August 31,
2015 and will respond and publish a final rule in late 2015 to be
effective January 1, 2016.
About AMS
American Shared Hospital Services provides turnkey technology
solutions for advanced radiosurgical and radiation therapy
services. AMS is the world leader in providing Gamma Knife
radiosurgery equipment, a non-invasive treatment for malignant and
benign brain tumors, vascular malformations and trigeminal
neuralgia (facial pain). The Company also offers the latest IGRT
and IMRT systems, as well as its proprietary Operating Room for the
21st CenturySM concept. AMS owns common stock in Mevion Medical
Systems, Inc., developer of the compact MEVION S250 Proton Therapy
System.
Safe Harbor Statement
This press release may be deemed to contain certain
forward-looking statements with respect to the financial condition,
results of operations and future plans of American Shared Hospital
Services, which involve risks and uncertainties including, but not
limited to, the risks of the Gamma Knife and radiation therapy
businesses. Further information on potential factors that could
affect the financial condition, results of operations and future
plans of American Shared Hospital Services is included in the
filings of the Company with the Securities and Exchange Commission,
including the Company's Annual Report on Form 10-K for the year
ended December 31, 2014, the Quarterly Report on Form 10-Q for the
quarter ended on March 31, 2015 and the definitive Proxy Statement
for the Annual Meeting of Shareholders held on June 16, 2015.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150727005268/en/
American Shared Hospital ServicesErnest A. Bates, M.D.,
415-788-5300Chairman and Chief Executive Officere.bates@ashs.comorBerkman AssociatesNeil
Berkman, 310-477-3118Presidentinfo@berkmanassociates.com
American Shared Hospital... (AMEX:AMS)
Historical Stock Chart
From Mar 2024 to Apr 2024
American Shared Hospital... (AMEX:AMS)
Historical Stock Chart
From Apr 2023 to Apr 2024